Hangzhou Yirui Pharmaceutical Technology Co., Ltd

This early-stage study tests a new oral drug called YR011 in 64 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo in single or multiple doses. The goal is to check for side effects and measure drug levels in the b…